SCHEMBL27807046

SCHEMBL27807046

O=CC1CCc2ccccc2N1CO

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.44
▸ CHRM4 P08173 2/20 0.44
▸ CHRM1 P11229 2/20 0.44
▸ CHRM3 P20309 1/20 0.43
▸ MTNR1A P48039 11/20 0.42
▸ MTNR1B P49286 1/20 0.40
▸ SRD5A1 P18405 1/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27585383 0.85 MTNR1A (0.44) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL28491796 0.83 CHRM2 (0.41) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL28229934 0.81 MTNR1A (0.55) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27570842 0.81 MTNR1A (0.40) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27312907 0.78 MTNR1A (0.41) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27570669 0.77 MTNR1A (0.40) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27844281 0.77 MTNR1A (0.49) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27929079 0.77 SRD5A1 (0.39) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27478880 0.77 SRD5A1 (0.39) CHRM2CHRM4CHRM1CHRM3MTNR1A
SCHEMBL27799208 0.77 MTNR1A (0.46) CHRM2CHRM4CHRM1CHRM3MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101754761-A compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents REVIVA PHARMACEUTICALS INC 2010-06-23 — — CN disclosed
Send feedback